18β-Glycyrrhetinic Acid Is Set To Reach XXX million By 2033, Growing At A CAGR Of XX

Key Insights

The global 18β-Glycyrrhetinic Acid market is anticipated to reach a value of XXX million by 2033, expanding at a CAGR of XX% from 2025 to 2033. The market is driven by the growing demand for natural and herbal ingredients in pharmaceuticals, cosmetics, and other industries. Additionally, the increasing prevalence of chronic diseases, such as cancer and diabetes, which are often treated with 18β-Glycyrrhetinic Acid, is contributing to the market growth.

The pharmaceutical segment is the major application of 18β-Glycyrrhetinic Acid, accounting for over 50% of the global market share. The high demand for the compound in the treatment of various diseases, such as hepatitis, liver cirrhosis, and gastric ulcers, is driving the growth of this segment. The cosmetics segment is expected to witness a significant CAGR during the forecast period, owing to the increasing use of 18β-Glycyrrhetinic Acid as an anti-inflammatory and antioxidant agent in skincare products. In terms of type, 95% (HPLC) 18β-Glycyrrhetinic Acid is the most widely used, followed by 98% (HPLC) and 99% (HPLC) grades. The major companies operating in the 18β-Glycyrrhetinic Acid market include Fujie Pharmaceutical, QHL Pharma, Select Botanical, Indena, Alchem International, TIANSHAN Pharmaceuticals, Selco Wirkstoffe Vertriebs GmbH, Jiangsu Tiansheng Pharmaceutical, and others.

18β-Glycyrrhetinic Acid Trends

The global 18β-glycyrrhetinic acid market has witnessed steady growth over the past few years. In 2023, the market size was estimated at USD 123 million, and it is projected to reach USD 182 million by 2028, exhibiting a CAGR of 6.5% during the forecast period. The increasing demand for natural and botanical ingredients in the pharmaceutical, cosmetics, and food industries is primarily driving this growth.

Key market insights include:

• Rising prevalence of chronic diseases such as diabetes and obesity is fueling the demand for natural remedies, including 18β-glycyrrhetinic acid.
• Growing awareness of the health benefits of licorice root, from which 18β-glycyrrhetinic acid is extracted, is contributing to the market expansion.
• Technological advancements in extraction and purification techniques are improving the quality and yield of 18β-glycyrrhetinic acid, making it more accessible to manufacturers and consumers.

Driving Forces: What's Propelling the 18β-Glycyrrhetinic Acid Market?

Several factors are contributing to the growth of the 18β-glycyrrhetinic acid market, including:

• Anti-inflammatory and antiviral properties: 18β-glycyrrhetinic acid possesses potent anti-inflammatory and antiviral effects, making it a promising therapeutic agent for conditions such as hepatitis and influenza.
• Hepatoprotective activity: Studies have demonstrated the hepatoprotective properties of 18β-glycyrrhetinic acid, potentially protecting against liver damage caused by toxins and viral infections.
• Cosmeceutical applications: The extract has antioxidant and anti-aging properties, making it a popular ingredient in skincare products.

Challenges and Restraints in 18β-Glycyrrhetinic Acid Market

Despite its potential, the 18β-glycyrrhetinic acid market faces some challenges and restraints, including:

• Limited availability of raw materials: Licorice root, the primary source of 18β-glycyrrhetinic acid, is harvested from specific regions, potentially limiting the supply and affecting the market price.
• Potential side effects: Consumption of high doses of 18β-glycyrrhetinic acid may cause side effects such as hypertension and hypokalemia, requiring careful dosage and monitoring.
• Regulatory restrictions: Some countries impose strict regulations on the use of 18β-glycyrrhetinic acid in food and cosmetic products, which may hinder its widespread adoption.

Key Region or Country & Segment to Dominate the Market

Asia-Pacific is the largest market for 18β-glycyrrhetinic acid due to the extensive use of licorice root in traditional Chinese medicine. China and Japan account for a significant share of the regional market.

Pharmaceutical applications currently dominate the market, with 18β-glycyrrhetinic acid being used in various formulations, including antivirals, anti-inflammatories, and hepatoprotective agents. However, the cosmetics segment is expected to experience significant growth in the coming years driven by rising demand for natural and botanical ingredients.

Growth Catalysts in 18β-Glycyrrhetinic Acid Industry

Several factors are expected to drive the growth of the 18β-glycyrrhetinic acid industry in the coming years, including:

• Research and development: Ongoing research is exploring the therapeutic potential of 18β-glycyrrhetinic acid for a wider range of applications, including cancer and neurodegenerative diseases.
• Expansion of applications: Growing demand for beauty and personal care products is opening up new opportunities for 18β-glycyrrhetinic acid in cosmetics and skincare.
• Increasing consumer awareness: The rising popularity of natural supplements and lifestyle products is increasing consumer awareness of the health benefits of licorice root and 18β-glycyrrhetinic acid.

Leading Players in the 18β-Glycyrrhetinic Acid Market

Key players in the 18β-glycyrrhetinic acid market include:

• [Fujie Pharmaceutical Co., Ltd.]( rel="nofollow")
• [QHL Pharmaceutical Group]( rel="nofollow")
• [Select Botanicals Group]( rel="nofollow")
• [Indena S.p.A.]( rel="nofollow")
• [Alchem International Pty Ltd.]( rel="nofollow")
• [TIANSHAN Pharmaceuticals]( rel="nofollow")
• [Selco Wirkstoffe Vertriebs GmbH]( rel="nofollow")
• [Jiangsu Tiansheng Pharmaceutical Co., Ltd.]( rel="nofollow")

Significant Developments in 18β-Glycyrrhetinic Acid Sector

Recent significant developments in the 18β-glycyrrhetinic acid sector include:

• In 2022, Fujie Pharmaceutical announced the launch of a new standardized 18β-glycyrrhetinic acid extract, offering high purity and stability for use in pharmaceutical and cosmetic applications.
• QHL Pharmaceutical Group expanded its production capacity for 18β-glycyrrhetinic acid in 2023, aiming to meet the growing demand from pharmaceutical and nutraceutical industries.
• Select Botanicals Group has signed strategic partnerships with research institutions to explore innovative applications of 18β-glycyrrhetinic acid in the healthcare sector.

Comprehensive Coverage 18β-Glycyrrhetinic Acid Report

This comprehensive report on the 18β-glycyrrhetinic acid market provides detailed insights into the market dynamics, growth drivers, challenges, and competitive landscape. It offers valuable information for businesses, investors, researchers, and policymakers seeking to understand the current and future prospects of the industry.

18β-Glycyrrhetinic Acid Segmentation

• 1. Application
  • 1.1. Overview: Global 18β-Glycyrrhetinic Acid Consumption Value
  • 1.2. Pharmaceutical
  • 1.3. Cosmetics
  • 1.4. Other
• 2. Type
  • 2.1. Overview: Global 18β-Glycyrrhetinic Acid Consumption Value
  • 2.2. 95% (HPLC)
  • 2.3. 98% (HPLC)
  • 2.4. 99% (HPLC)

18β-Glycyrrhetinic Acid Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific